Perspective Therapeutics CATX Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's additional paid-in capital?
- Perspective Therapeutics (CATX) reported additional paid-in capital of $708.58M in Q1 2026.
- How has Perspective Therapeutics's additional paid-in capital changed year-over-year?
- Perspective Therapeutics's additional paid-in capital increased by 32.6% year-over-year, from $534.45M to $708.58M.
- What is the long-term trend for Perspective Therapeutics's additional paid-in capital?
- Over 5 years (2020 to 2025), Perspective Therapeutics's additional paid-in capital has grown at a 39.6% compound annual growth rate (CAGR), from $102.21M to $541.69M.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.